Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Boston Scientific receives Japanese approval for Acuity heart failure lead

Boston Scientific : 15 April, 2008  (New Product)
The Japanese Ministry of Health, Labor and Welfare (MHLW) has given approval of Boston Scientific’s Acuity Steerable left ventricular lead for use with cardiac resynchronization therapy (CRT) devices, which treat heart failure.
The company also received reimbursement approval for the lead from the National Health Insurance System and plans to launch the product immediately in Japan.

The Acuity Steerable left ventricular lead features a deflectable tip for successful delivery in simple, compound and complex anatomies, which includes placement of the lead in difficult-to-access branch vessels on the left side of the heart. A lead is an insulated wire that carries the heart signal to the implanted device and delivers energy from the device to the heart. In most cases, leads are passed into the heart through veins.

'We are pleased to make this lead available to physicians in Japan so they can offer this advanced therapy to their heart failure patients,' said Fred Colen, executive vice president, operations and technology, Boston Scientific Cardiac Rhythm Management. 'The Acuity Steerable lead, when teamed with our CRT devices, provides a proven, effective treatment option to patients who struggle with heart failure.'

The Acuity Steerable lead also provides physicians with four configurations for stimulating the left side of the heart, which Boston Scientific refers to as Electronic Repositioning. This ability allows physicians to change the stimulation site non-invasively after implant, which helps avoid the need for an additional surgical procedure. Boston Scientific is the only company that provides physicians with four left ventricular pacing configurations.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo